Cargando…

Botulinum toxin therapy: functional silencing of salivary disorders

Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary fistulae that may have a post-traumatic or pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovato, A., Restivo, D.A., Ottaviano, G., Marioni, G., Marchese-Ragona, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SRL 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463526/ https://www.ncbi.nlm.nih.gov/pubmed/28516981 http://dx.doi.org/10.14639/0392-100X-1608

Ejemplares similares

Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated
por: Restivo, Domenico A., et al.
Publicado: (2018)

The superior laryngeal nerve injury of a famous soprano, Amelita Galli-Curci
por: MARCHESE-RAGONA, R., et al.
Publicado: (2013)

Ultrasound guided injection of botulinum toxin into the salivary glands of children with neurological disorders
por: Matsuoka, Marcia Wang, et al.
Publicado: (2016)

Intraductal Salivary Gland Infusion With Botulinum Toxin
por: Schwalje, Adam T., et al.
Publicado: (2019)

Effect of Botulinum Toxin A Injection into the Salivary Glands for Sialorrhea in Children with Neurologic Disorders
por: Jeung, In Seuk, et al.
Publicado: (2012)

Loss of smell in COVID-19 patients: a critical review with emphasis on the use of olfactory tests
por: Marchese-Ragona, Rosario, et al.
Publicado: (2020)

Botulinum toxin A inhibits salivary secretion of rabbit submandibular gland
por: Shan, Xiao-Feng, et al.
Publicado: (2013)

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Type a botulinum toxin in the management of spontaneous salivary otorrhea: a case report
por: Chan, Teffran J., et al.
Publicado: (2020)

Use of botulinum toxin for movement disorders
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2019)

Botulinum Toxin in Movement Disorders: An Update
por: Anandan, Charenya, et al.
Publicado: (2021)

Dysphagia in neurological diseases: a literature review
por: Panebianco, M., et al.
Publicado: (2020)

Botulinum toxin treatment of salivary fistulas following parotidectomy: follow-up results
por: Laskawi, Rainer, et al.
Publicado: (2012)

Combined laryngeal cleft injection laryngoplasty and salivary botulinum toxin for saliva aspiration
por: Nguyen, Justin, et al.
Publicado: (2022)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

History of Botulinum Toxin Treatment in Movement Disorders
por: Jabbari, Bahman
Publicado: (2016)

Experiences on The Administration of Botulinum Toxin in Movement Disorders
por: Tuğan Yıldız, Buket, et al.
Publicado: (2021)

Effect of Botulinum Toxin Type A on Morphology of Salivary Glands in Patients with Cerebral Palsy
por: Lee, Zee-Ihn, et al.
Publicado: (2011)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders
por: Lin, Yu-Hua, et al.
Publicado: (2020)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
por: Hung, Fan-Ching, et al.
Publicado: (2022)

Botulinum toxin therapy: past, present and future developments
por: Dressler, Dirk, et al.
Publicado: (2022)

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System
por: Yoshida, Kazuya
Publicado: (2022)

Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study
por: Lehnert, Franziska, et al.
Publicado: (2023)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Accuracy of Ultrasound-Guided and Non-ultrasound-Guided Botulinum Toxin Injection Into Cadaver Salivary Glands
por: So, Jae In, et al.
Publicado: (2017)

Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders
por: Alfonsi, Enrico, et al.
Publicado: (2017)

Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
por: Marquez-Vazquez, Juan Francisco, et al.
Publicado: (2022)

Botulinum toxin: An emerging therapy in female bladder outlet obstruction
por: Pradhan, Aditya A.
Publicado: (2009)

Botulinum toxin for treatment of restrictive strabismus()
por: Merino, Pilar S., et al.
Publicado: (2017)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic
por: Neeraja, Koti, et al.
Publicado: (2021)

Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2014)

Postsurgical Refractory Gastroparesis: Response to Botulinum Toxin Therapy
por: Sarvepalli, Deepika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f07si98g8mj2n6qv5krj52r79a